Ondansetron盐酸盐是5-HT3受体拮抗剂,可作为化疗后止吐剂。
Ondansetron is a serotonin 5-HT3 receptor antagonist, used to prevent nausea and vomiting caused by cancer chemotherapy, and radiation therapy.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Pinelli A, et al. Eur J Pharmacol,?997, 340(2-3), 111-119.
分子式 C18H19N3O.HCl |
分子量 329.82 |
CAS号 99614-01-4 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 60 mg/mL |
Water 20 mg/mL |
Ethanol 10 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT01759420 | Ondansetron | Drug: Ondansetron | C.R.Darnall Army Medical Center|Madigan Army Medical Center | 2012-12-01 | 2014-06-24 | |
NCT00934180 | Healthy | Drug: Ondansetron|Drug: Zofran | Teva Pharmaceuticals USA | Phase 1 | 2002-12-01 | 2009-07-08 |
NCT00934921 | Healthy | Drug: Ondansetron|Drug: Zofran | Teva Pharmaceuticals USA | Phase 1 | 2003-02-01 | 2009-07-08 |
NCT00946387 | Nausea|Vomiting | Drug: Ondansetron HCl 24 mg Tablets (Sandoz, Inc.)|Drug: Zofran (Ondansetron HCl) 24 mg Tablets (GlaxoSmithKline) | Sandoz | Phase 1 | 2004-09-01 | 2009-07-24 |
NCT00947128 | Nausea|Vomiting | Drug: Ondansetron HCl 24 mg Tablets (Sandoz, Inc.)|Drug: Zofran (Ondansetron HCl) 24 mg Tablets (GlaxoSmithKline) | Sandoz | Phase 1 | 2004-09-01 | 2009-07-24 |
NCT02901054 | Pain | Drug: Ondansetron | Washington University School of Medicine | 2016-08-01 | 2016-10-13 | |
NCT02473887 | Gastroenteritis | Drug: Ondansetron with1:1 ORA - sweet. | Hamad Medical Corporation | Phase 1 | 2014-09-01 | 2015-06-14 |
NCT00890149 | Alcohol Abuse|Alcoholism | Drug: Ondansetron + BASICS Plus|Drug: Placebo + BASICS Plus | Bankole A. Johnson|National Institute on Alcohol Abuse and Alcoholism (NIAAA)|University of Maryland | Phase 2 | 2015-09-01 | 2015-12-03 |
NCT03052361 | Gastroenteritis | Drug: Ondansetron|Drug: Placebos | St. Justine's Hospital | Phase 2|Phase 3 | 2017-06-01 | 2017-02-13 |
NCT01896440 | Malignant Childhood Neoplasm | Drug: Ondansetron | University of Oklahoma | Phase 4 | 2013-10-01 | 2013-10-04 |
NCT01801475 | Postoperative Nausea | Drug: Ondansetron | Stanford University | Phase 1|Phase 2 | 2013-01-01 | 2015-05-28 |
NCT00796497 | Obsessive Compulsive Disorder | Drug: ondansetron | Institute of Neuroscience, Florence, Italy | Phase 4 | 2008-03-01 | 2011-02-23 |
NCT02985840 | Nausea|Abdominal Pain | Drug: Ondansetron|Drug: Dexamethasone | OhioHealth | Phase 4 | 2013-10-01 | 2017-01-25 |
NCT00678457 | Alcohol Dependence | Drug: Ondansetron|Drug: Olanzapine|Drug: Placebo | University of Virginia | Phase 2 | 2007-01-01 | 2009-01-29 |
NCT01275248 | Obsessive-compulsive Disorder | Drug: Ondansetron|Drug: Placebo | Transcept Pharmaceuticals | Phase 2 | 2011-01-01 | 2013-01-16 |
NCT00387556 | Conscious Sedation | Drug: Ondansetron | University of Colorado, Denver | 2002-12-01 | 2013-05-09 | |
NCT02296333 | Postoperative Pain | Drug: ondansetron|Drug: isotonic | Mustafa Kemal University | Phase 4 | 2014-05-01 | 2015-03-12 |
NCT01815125 | Traumatic Brain Injury|Brain Concussion | Drug: Ondansetron|Drug: PLacebo | St. Justine's Hospital | Phase 1 | 2013-03-01 | 2015-09-28 |
NCT02460341 | Brain Function|Healthy Adults | Drug: ondansetron|Drug: placebo | Icahn School of Medicine at Mount Sinai | Phase 4 | 2015-08-01 | 2016-09-12 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们